TechSeeker Profile

H Lundbeck A/S (AKA:Lundbeck)
Profile last edited on: 3/23/2022

NO Business Identifier is currently available for this company.
TS Type
Non SBIR Small firm collaborator
Status
Year Founded
N/A
Last Involved Year
2019

Key People / Management

Location Information

Ottiliavej 9
Copenhagen, DK 60015
   (866) 337-6996
   www.lundbeck.com

Public Profile

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. The Company is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, including Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. The Company’s product portfolio includes such pharmaceuticals, as Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. Additionally, the Company had a number of products in development phases. As of December 31, 2012, it was active through subsidiaries in 57 countries, including Argentina, Australia, Denmark, China, Russia, the United States and the United Kingdom, among others.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
Denmark
Employment
5,379
Revenue
N/A
Public/Private
Privately Held
Stock Info
---
Received SBIR $$
No

Techseeker firm in the news

There are no news available.